Journal/
conference: PLOS ONE
conference: PLOS ONE
Research:Paper
Organisation/s:
The University of Melbourne, University of Waterloo, Canada
Funder:
This study was supported by
grants from the US National Cancer Institute (P01
CA200512), the Canadian Institutes of Health
Research (FDN-148477), the National Health and
Medical Research Council of Australia (APP
1106451), and Health Canada’s Substance Use and
Addictions Program (SUAP) (2021-HQ-000058).
GTF was supported by a Senior Investigator Award
from the Ontario Institute for Cancer Research (IA-
004) and the Canadian Cancer Society 2020 O.
Harold Warwick Prize. RJO and AH are supported
by a Tobacco Centers of Regulatory Science US
National Cancer Institute grant (U54 CA238110).